Study Start Up and Enrollment
Case Study
Mar 04, 2019
IQVIA Biotech was approached by a clinical-stage biopharmaceutical company to run its Phase II prostate cancer drug trial in the U.S. For the Phase II trial, the sponsor was searching for a CRO with an oncology-dedicated group, specific prostate cancer expertise, an ability to be flexible in implementation, and a willingness to provide transparency in the trial’s execution.
You may also be interested in
Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.